Wael Hashad - Net Worth and Insider Trading

Wael Hashad Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wael Hashad owns 1 companies in total, including Seres Therapeutics Inc (MCRB) .

Click here to see the complete history of Wael Hashad’s form 4 insider trades.

Insider Ownership Summary of Wael Hashad

Ticker	Comapny	Transaction Date	Type of Owner
MCRB	Seres Therapeutics Inc	2015-12-29	EVP & Chief Commercial Officer

Wael Hashad Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wael Hashad Ownership Network

Ownership Network List of Wael Hashad

No Data

Ownership Network Relation of Wael Hashad

Wael Hashad Owned Company Details

What does Seres Therapeutics Inc do?

Who are the key executives at Seres Therapeutics Inc?

Wael Hashad is the EVP & Chief Commercial Officer of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and See Remarks Thomas Desrosier .

Seres Therapeutics Inc (MCRB) Insider Trades Summary

Over the past 18 months, Wael Hashad made no insider transaction in Seres Therapeutics Inc (MCRB). Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 32,192 shares made by Teresa L. Young , a net sale of 18,332 shares made by David S. Ege , and a net sale of 25,054 shares made by Eric D. Shaff .

In summary, during the past 3 months, insiders sold 31,623 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 31,623 shares. During the past 18 months, 116,712 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,712 shares.

Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Seres Therapeutics Inc Insider Transactions

No Available Data

Wael Hashad Mailing Address

Above is the net worth, insider trading, and ownership report for Wael Hashad. You might contact Wael Hashad via mailing address: C/o Seres Therapeutics, Inc., 215 First Street, Cambridge Ma 02142.

Discussions on Wael Hashad

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.